QNRX · Forms 3, 4, 5
Insider trades at Quoin Pharmaceuticals Ltd.
4 insiders bought $280K of Quoin Pharmaceuticals Ltd. stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for Quoin Pharmaceuticals Ltd. (QNRX) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Denise P. Carter | Chief Operating Officer | Buy | 20,490 | $4.88 | $100K | Form 4 | |
| Michael Myers | Chief Executive Officer | Buy | 20,490 | $4.88 | $100K | Form 4 | |
| Sally Bridget Lawlor | Chief Financial Officer | Buy | 10,244 | $4.88 | $50K | Form 4 | |
| Anthony James Culverwell | Director | Buy | 6,146 | $4.88 | $30K | Form 4 | |
| Dennis Langer | Director | Award | 34,534 | $5.15 | $178K | Form 4 | |
| Anthony James Culverwell | Director | Award | 31,352 | $5.15 | $161K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.